MicroConstants, a GLP-compliant Contract Research Organization (CRO) specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier. In multiple cases,... (Continue reading)
INTERPHEX Asia, a platform for showcasing latest technologies and expertise to the pharmaceutical and biopharmaceutical industry players in Asia will be held at Suntec International Convention & Exhibition Centre , Singapore on June 7 & 8, 2010. At the same time... (Continue reading)
Chiltern International Limited, a global contract research organization (CRO), announced its latest collaboration with Charles River Laboratories, Inc. As part of this collaboration, Chiltern Early Phase will partner with Charles River to conduct and support early phase radiolabelled studies. Glenn Kerkhof,... (Continue reading)
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, announced that it has signed an agreement to lease its facility in East Windsor, NJ, commencing February 1, 2010. The lease agreement also contains an... (Continue reading)